Phase 3 Randomized Study of Isatuximab (isa) Plus Lenalidomide and Dexamethasone (rd) with Bortezomib Versus Isard in Patients with Newly Diagnosed Transplant Ineligible Multiple Myeloma (NDMM TI).Xavier Leleu,Cyrille Hulin,Jerome Lambert,Arthur Bobin,Aurore Perrot,Salomon Manier,Arnaud Jaccard,Lydia Montes,Lionel Karlin,Pascal Godmer,Thomas Chalopin,Borhane Slama,Marie Lorraine Chretien,Karim Laribi,Claire Dingremont,Christophe Roul,Clara Mariette,Sophie Rigaudeau,Margaret Macro,Mohamad Mohty,Cyrille Touzeau,Philippe Moreau,Herve Avet-Loiseau,Jill Corre,Thierry FaconJournal of Clinical Oncology（2024）引用 0|浏览8AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
